Myeong-Jin Kim

Myeong-Jin Kim

Auto-generated profile, based on publicly available information

Myeong-Jin Kim

Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in RadioGraphics
Verified
Journal Article
Closed access
YCYong Eun Chung
Yong Eun Chung
MKMyeong-Jin Kim
Myeong-Jin Kim
YPYoung Nyun Park
Young Nyun Park
JCJin-Young Choi
Jin-Young Choi
JPJu Yeon Pyo
Ju Yeon Pyo
SCSun Young Choi
Sun Young Choi
Intrahepatic cholangiocarcinoma is the second most common primary hepatic tumor. Various risk factors have been reported for intrahepatic cholangiocarcinoma, and the radiologic and pathologic findings of this disease entity may differ depending on the underlying risk factors. Intrahepatic cholangiocarcinoma can be classified into three types on the basis of gross morphologic features: mass-forming (the most common), periductal infiltrating, and intraductal growth. At computed tomography (CT), mass-forming intrahepatic cholangiocarcinoma usually appears as a homogeneous low-attenuation mass with irregular peripheral enhancement and can be accompanied by capsular retraction, satellite nodules, and peripheral intrahepatic duct dilatation. Periductal infiltrating cholangiocarcinoma is characterized by growth along the dilated or narrowed bile duct without mass formation. At CT and magnetic resonance imaging, diffuse periductal thickening and increased enhancement can be seen with a dilated or irregularly narrowed intrahepatic duct. Intraductal cholangiocarcinoma may manifest with various imaging patterns, including diffuse and marked ductectasia either with or without a grossly visible papillary mass, an intraductal polypoid mass within localized ductal dilatation, intraductal castlike lesions within a mildly dilated duct, and a focal stricture-like lesion with mild proximal ductal dilatation. Awareness of the underlying risk factors and morphologic characteristics of intrahepatic cholangiocarcinoma is important for accurate diagnosis and for differentiation from other hepatic tumorous and nontumorous lesions.

1 October 2004 in European Journal of Radiology
Verified
Journal Article
Closed access
JKJoo Hee Kim
Joo Hee Kim
GBGeerard Beets
Geerard Beets
MKMyeong-Jin Kim
Myeong-Jin Kim
AKAlfons G.H. Kessels
Alfons G.H. Kessels
RBRegina G.H. Beets-Tan
Regina G.H. Beets-Tan

1 May 2010 in Radiology
Verified
Journal Article
Open access
SASung Soo Ahn
Sung Soo Ahn
MKMyeong-Jin Kim
Myeong-Jin Kim
JLJoon Seok Lim
Joon Seok Lim
HHHye-Suk Hong
Hye-Suk Hong
YCYong Eun Chung
Yong Eun Chung
JCJin-Young Choi
Jin-Young Choi
To determine the added value of hepatobiliary phase images in gadoxetic acid-enhanced magnetic resonance (MR) imaging in the evaluation of hepatocellular carcinoma (HCC). Institutional review board approved this retrospective study and waived the informed consent. Fifty-nine patients with 84 HCCs underwent gadoxetic acid-enhanced MR examinations that included 20-minute delayed hepatobiliary phase imaging. MR imaging was performed with a 1.5-T system in 19 patients and a 3.0-T system in 40 patients. A total of 113 hepatic nodules were documented for analysis. Three radiologists independently reviewed two sets of MR images: set 1, unenhanced (T1- and T2-weighted) and gadoxetic acid-enhanced dynamic images; set 2, hepatobiliary phase images and unenhanced and gadoxetic acid-enhanced dynamic images. For each observer, the diagnostic accuracy was compared by using the area under the alternative free-response receiver operating characteristic curve (A(z)). Sensitivity and specificity were also calculated and compared between the two sets. For all observers, A(z) values were higher with the addition of the hepatobiliary phase. The observer who had the least experience in abdominal imaging (2 years) demonstrated significant improvement in A(z), from 0.895 in set 1 to 0.951 in set 2 (P = .049). Sensitivity increased with the addition of hepatobiliary phase images but did not reach statistical significance. Nine HCCs (10.7%) in six patients (10.1%) were seen only on hepatobiliary phase images. Hepatobiliary phase images obtained after gadoxetic acid-enhanced dynamic MR imaging may improve diagnosis of HCC and assist in surgical planning.

1 August 2015 in Radiology
Verified
Journal Article
Closed access
CAChansik An
Chansik An
DKDong Wook Kim
Dong Wook Kim
YPYoung Nyun Park
Young Nyun Park
YCYong Eun Chung
Yong Eun Chung
HRHyungjin Rhee
Hyungjin Rhee
MKMyeong-Jin Kim
Myeong-Jin Kim
To identify magnetic resonance (MR) imaging features that enable prediction of early recurrence (<2 years) after curative resection of hepatocellular carcinoma (HCC) and to derive a preoperative prediction model. This retrospective study was approved by the institutional review board. The requirement to obtain written informed consent was waived. A total of 268 patients who underwent hepatic resection for a single HCC from January 2008 to August 2011 were divided into two cohorts: a training cohort, which was used to derive a prediction model (n = 187), and a validation cohort (n = 81). All MR images from the training cohort were reviewed by two radiologists. A prediction model was constructed by using MR imaging features that were independently associated with early recurrence with use of multiple logistic regression analysis. The performance of the prediction model in the validation cohort was evaluated with respect to discrimination (ie, whether the relative ranking of individual predictions of subsequent early recurrence is in the correct order). In the training cohort, four MR imaging features were independently associated with early recurrence: rim enhancement (odds ratio [OR] = 3.83; 95% confidence interval [CI]: 1.39, 10.52), peritumoral parenchymal enhancement in the arterial phase (OR = 2.64; 95% CI: 1.27, 5.46), satellite nodule (OR = 4.07; 95% CI: 1.09, 15.21), and tumor size (OR = 1.66; 95% CI: 1.31, 2.09). A prediction model derived from these variables showed an area under the receiver operating characteristic curve (AUC) of 0.788 in the prediction of the risk of early recurrence in the training cohort. When applied to the validation cohort, this model showed good discrimination (AUC, 0.783). The prediction model derived from rim enhancement, peritumoral parenchymal enhancement, satellite nodule, and tumor size can be used preoperatively to estimate the risk of early recurrence after resection of a single HCC.

1 June 1999 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
NKNam Kyu Kim
Nam Kyu Kim
MKMyung Jin Kim
Myung Jin Kim
SYSeong Hyeon Yun
Seong Hyeon Yun
SSSeung Kook Sohn
Seung Kook Sohn
JMJin Sik Min
Jin Sik Min
PURPOSE:The preoperative assessment of rectal cancer wall invasion and regional lymph node metastasis is essential for the planning of optimal therapy. This study was done to determine the accuracy and clinical usefulness of transrectal ultrasonography, pelvic computed tomography, and magnet

1 July 2019 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SKSungwon Kim
Sungwon Kim
JSJaeseung Shin
Jaeseung Shin
DKDo-Young Kim
Do-Young Kim
GCGi Hong Choi
Gi Hong Choi
MKMyeong-Jin Kim
Myeong-Jin Kim
JCJin-Young Choi
Jin-Young Choi
Purpose: To evaluate the usefulness of the radiomic model in predicting early (≤2 years) and late (>2 years) recurrence after curative resection in cases involving a single hepatocellular carcinoma (HCC) 2–5 cm in diameter using preoperative gadoxetic acid–enhanced magnetic resonance imaging (MRI), in comparison with the clinicopathologic model. Experimental Design: This retrospective study included 167 patients with surgically resected and pathologically confirmed single HCC 2–5 cm in diameter (n = 167, training set:validation set = 128:39) who underwent preoperative gadoxetic acid–enhanced MRI between January 2010 and December 2015. A radiomic model, a clinicopathologic model, and a combined clinicopathologic-radiomic (CCR) model were built using a random survival forest to predict disease-free survival (DFS) in the following conditions: early DFS versus late DFS, dynamic phases, and the peritumoral area included in the segmentation. Results: The radiomic model showed a prognostic performance comparable with the clinicopathologic model only with 3-mm peritumoral border extension [c-index difference (radiomic-clinicopathologic), −0.021, P = 0.758]. The CCR model with the 3-mm border extension showed the highest c-index value but no statistically significant improvement over the clinicopathologic model [CCR, 0.716 (0.627–0.799); clinicopathologic model, 0.696 (0.557–0.799)]. Conclusions: The prognostic value of the preoperative radiomic model with 3-mm border extension showed comparable performance with that of the postoperative clinicopathologic model for predicting DFS of early recurrence of HCC using gadoxetic acid–enhanced MRI. This suggests the importance of including peritumoral changes in the radiomic analysis of HCC.